In clinical trials, retatrutide has been administered via subcutaneous injection on a once-weekly basis, with doses escalating gradually over several weeks to improve tolerability
This increases actual concentration slightly a 53mg vial reconstituted with 2mL yields 26.5mg/mL instead of 25mg/mL
Both subcutaneous and intramuscular Injections are a means to deliver vitamins, minerals, and nutrients to the body while avoiding the digestive process
[15] Biotins mechanism of action in the body stems from its role as an essential cofactor for several carboxylase enzymes involved in key metabolic pathways
No hepatotoxicity, nephrotoxicity, or cardiovascular adverse events have been reported in clinical or preclinical studies
Understanding these mechanisms provides insight into how this peptide produces its body composition effects